After changing its name and identity, cannabis and psychedelics provider Melodiol (ASX: ME1) has decided to sell off two of…
In Australia, over 200,000 people live with epilepsy, a chronic neurological condition that is often characterised by seizures. Thousands are…
The budding cannabis market in New Zealand continues to flourish as more Kiwis seek an alternative to standard pharmaceutical drugs.…
The burgeoning arms of cannabis treatment have made their way to Ireland, with regulators easing restrictions which has increased the…